Tang Ke - Net Worth and Insider Trading
Tang Ke Net Worth
The estimated net worth of Tang Ke is at least $171,300 dollars as of 2024-06-23. Tang Ke is the senior management of Yabao Pharmaceutical Group Co Ltd and owns about 30,000 shares of Yabao Pharmaceutical Group Co Ltd (SHSE:600351) stock worth over $171,300. Details can be seen in Tang Ke's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Tang Ke has not made any transactions after 2017-06-02 and currently still holds the listed stock(s).
Transaction Summary of Tang Ke
Tang Ke Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tang Ke owns 1 companies in total, including Yabao Pharmaceutical Group Co Ltd (SHSE:600351) .
Click here to see the complete history of Tang Ke’s form 4 insider trades.
Insider Ownership Summary of Tang Ke
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:600351 | Yabao Pharmaceutical Group Co Ltd | 2017-06-02 | senior management |
Tang Ke Latest Holdings Summary
Tang Ke currently owns a total of 1 stock. Tang Ke owns 30,000 shares of Yabao Pharmaceutical Group Co Ltd (SHSE:600351) as of June 2, 2017, with a value of $171,300.
Latest Holdings of Tang Ke
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:600351 | Yabao Pharmaceutical Group Co Ltd | 2017-06-02 | 30,000 | 5.71 | 171,300 |
Holding Weightings of Tang Ke
Tang Ke Form 4 Trading Tracker
According to the SEC Form 4 filings, Tang Ke has made a total of 0 transactions in Yabao Pharmaceutical Group Co Ltd (SHSE:600351) over the past 5 years. The most-recent trade in Yabao Pharmaceutical Group Co Ltd is the acquisition of 30,000 shares on June 2, 2017, which cost Tang Ke around $216,000.
Insider Trading History of Tang Ke
- 1
Tang Ke Trading Performance
GuruFocus tracks the stock performance after each of Tang Ke's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tang Ke is 14.19%. GuruFocus also compares Tang Ke's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tang Ke within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Tang Ke's insider trading performs compared to the benchmark.
Performance of Tang Ke
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.76 | | | | | |
| Relative Return to S&P 500(%) | 9.4 | | | | | |
Tang Ke Ownership Network
Tang Ke Owned Company Details
What does Yabao Pharmaceutical Group Co Ltd do?
Who are the key executives at Yabao Pharmaceutical Group Co Ltd?
Tang Ke is the senior management of Yabao Pharmaceutical Group Co Ltd. Other key executives at Yabao Pharmaceutical Group Co Ltd include senior management Zuo Zhe Feng , Supervisors Xu Zhen Jiang , and senior management Wang Gang .
Yabao Pharmaceutical Group Co Ltd (SHSE:600351) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Yabao Pharmaceutical Group Co Ltd (SHSE:600351) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Yabao Pharmaceutical Group Co Ltd (SHSE:600351) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Yabao Pharmaceutical Group Co Ltd (SHSE:600351)'s detailed insider trading history can be found in Insider Trading Tracker table.
Yabao Pharmaceutical Group Co Ltd Insider Transactions
Tang Ke Mailing Address
Above is the net worth, insider trading, and ownership report for Tang Ke. Currently GuruFocus does not have mailing address information for Tang Ke.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
